RAJIV A PATEL
CIK 1275110 · last filed 2021-05-21
RAJIV A PATEL is a corporate insider who has filed 28 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider sold $365.6M of PLYA on May 21, 2021. Across all open-market trades the lifetime net is −$932.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $147.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$147.09M
6
28
-$932.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Playa Hotels & Resorts N.V. (PLYA) Delisted | 8,767,583 | $13.48 | $118.19M | -$365.59M | 1 | 2021-05-21 | |
| Nexvet Biopharma plc (NVET) Delisted | Director | 2,662,276 | — | — | $0 | 17 | 2017-07-05 |
| HPP | 10%+ Owner | 1,449,879 | $14.87 | $21.56M | -$537.52M | 2 | 2014-03-27 |
| EPL OIL & GAS, INC. (EPL) Delisted | 10%+ Owner | 4,449,629 | — | — | -$38.40M | 1 | 2010-03-25 |
| CLUB | 10%+ Owner | 5,143,904 | $24.40 | $125.53M | -$5.53M | 3 | 2010-02-19 |
| KNOLOGY INC (KNOL) Delisted | 10%+ Owner | 4,664,250 | — | — | $14.26M | 3 | 2007-11-14 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-21 | Playa Hotels & Resorts N.V. (PLYA) Delisted | Sell (S) | −53,138,512 | -$365.59M | EDGAR |
| 2017-08-02 | — | Disp (D) | −13,580 | -$91.3K | |
| 2017-07-05 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +4,100 | $512 | EDGAR |
| 2017-04-03 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2017-01-04 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2016-10-04 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2016-09-07 | Nexvet Biopharma plc (NVET) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-07-01 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +3,600 | $450 | EDGAR |
| 2016-07-01 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
| 2016-04-01 | Nexvet Biopharma plc (NVET) Delisted | Exer (M) | +500 | $62 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.